Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-FDG PET/CT Identifies Predictors of Survival in Patients with Locally Advanced Cervical Carcinoma and Paraaortic Lymph Node Involvement to Allow Intensification of Treatment.
Leray H, Gabiache E, Courbon F, Brenot-Rossi I, Colineaux H, Lepage B, Lambaudie E, Martinez A, Voglimacci M, Weyl A, Deslandres M, Ducassou A, Motton S, Vaysse C, Chantalat E. Leray H, et al. Among authors: ducassou a. J Nucl Med. 2020 Oct;61(10):1442-1447. doi: 10.2967/jnumed.119.238824. Epub 2020 Feb 7. J Nucl Med. 2020. PMID: 32034109 Free article.
Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
Angeles MA, Baissas P, Leblanc E, Lusque A, Ferron G, Ducassou A, Martínez-Gómez C, Querleu D, Martinez A. Angeles MA, et al. Among authors: ducassou a. Int J Gynecol Cancer. 2019 Mar;29(3):480-486. doi: 10.1136/ijgc-2018-000168. Epub 2019 Feb 1. Int J Gynecol Cancer. 2019. PMID: 30712019
Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Voglimacci M, Gabiache E, Lusque A, Ferron G, Ducassou A, Querleu D, Motton S, Chantalat E, Courbon F, Martinez A. Voglimacci M, et al. Among authors: ducassou a. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1551-1559. doi: 10.1007/s00259-018-4219-5. Epub 2019 Feb 7. Eur J Nucl Med Mol Imaging. 2019. PMID: 30729273
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
Martinez A, Voglimacci M, Lusque A, Ducassou A, Gladieff L, Dupuis N, Angeles MA, Martinez C, Tanguy Le Gac Y, Chantalat E, Hitzel A, Courbon F, Ferron G, Gabiache E. Martinez A, et al. Among authors: ducassou a. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1252-1260. doi: 10.1007/s00259-019-04659-z. Epub 2020 Jan 8. Eur J Nucl Med Mol Imaging. 2020. PMID: 31915897
Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer.
Mallet E, Angeles MA, Cabarrou B, Chardin D, Viau P, Frigenza M, Navarro AS, Ducassou A, Betrian S, Martínez-Gómez C, Tanguy Le Gac Y, Chantalat E, Motton S, Ferron G, Barranger E, Gabiache E, Martinez A. Mallet E, et al. Among authors: ducassou a. Clin Nucl Med. 2021 Oct 1;46(10):797-806. doi: 10.1097/RLU.0000000000003785. Clin Nucl Med. 2021. PMID: 34238796
[Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial].
Charra-Brunaud C, Salleron J, Menoux I, Peignaux K, Ducassou A, Petit A, Pommier P, Barillot I, Serre AA, Thomas L, Delannes M, Thibouw D, Antoni D, Renard S, Peiffert D. Charra-Brunaud C, et al. Among authors: ducassou a. Cancer Radiother. 2022 May;26(3):474-480. doi: 10.1016/j.canrad.2021.06.030. Epub 2021 Jul 21. Cancer Radiother. 2022. PMID: 34301498 Clinical Trial. French.
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
Martinez A, Lecuru F, Bizzarri N, Chargari C, Ducassou A, Fagotti A, Fanfani F, Scambia G, Cibula D, Díaz-Feijoo B, Gil Moreno A, Angeles MA, Muallem MZ, Kohler C, Luyckx M, Kridelka F, Rychlik A, Gerestein KG, Heinzelmann V, Ramirez PT, Frumovitz M, Ferron G, Betrian S, Filleron T, Fotopoulou C, Querleu D; PAROLA Study group. Martinez A, et al. Among authors: ducassou a. Int J Gynecol Cancer. 2023 Feb 6;33(2):293-298. doi: 10.1136/ijgc-2022-004223. Int J Gynecol Cancer. 2023. PMID: 36717163 Clinical Trial.
Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer.
Boyrie S, Charra-Brunaud C, Harter V, Ducassou A, Kirova Y, Barillot I, Krzisch C, Lang P, Baron MH, Montbarbon X, Delannes M, Peiffert D. Boyrie S, et al. Among authors: ducassou a. Brachytherapy. 2014 Jul-Aug;13(4):326-31. doi: 10.1016/j.brachy.2014.03.003. Brachytherapy. 2014. PMID: 24946972 Clinical Trial.
69 results